Bioprinting is a powerful technique for the rapid and reproducible fabrication of constructs for tissue engineering applications. In this study, both cartilage and skin analogs were fabricated after bioink pre-cellularization utilizing a novel passive mixing unit technique. This technique was developed with the aim to simplify the steps involved in the mixing of a cell suspension into a highly viscous bioink. The resolution of filaments deposited through bioprinting necessitates the assurance of uniformity in cell distribution prior to printing to avoid the deposition of regions without cells or retention of large cell clumps that can clog the needle. We demonstrate the ability to rapidly blend a cell suspension with a bioink prior to bioprinting of both cartilage and skin analogs. Both tissue analogs could be cultured for up to 4 weeks. Histological analysis demonstrated both cell viability and deposition of tissue specific extracellular matrix (ECM) markers such as glycosaminoglycans (GAGs) and collagen I respectively.
Introduction
In recent years, three-dimensional (3D) bioprinting technology has become more accessible to researchers, allowing the technique to become more widely utilized for fabrication of tissue analogs. Bioprinting promises to revolutionize biomedical research by facilitating the rapid and repeatable fabrication of multifaceted tissue constructs. The crux of the bioprinting technology lays in the ability to precisely control the deposition of biomaterials (known as bioinks) in three dimensions. This allows the generation of complex scaffolds with distinct regions of matrix compositions, bioactive factors, and cells that can more accurately recapitulate native tissue structure.
Bioprinting has been utilized for the fabrication of constructs for many tissue applications including cartilage 1 , skin 2 , muscle 3 , and bone 4 . These tissues are attractive for bioprinting due to their intrinsic striated micro-architectures that are suitable for recapitulation via layer-by-layer deposition. In particular, skin possesses a well-defined multilayered structure 5 , which is suitable for fabrication through layer-by-layer deposition techniques such as bioprinting. Additionally, bioprinting can be utilized to generate constructs that possess the necessary anatomical dimensions and shapes to repair the tissue defect. The ability to generate biomaterials with patient-specific size and shape 6 can begin to address the demand for partial repairs of many tissues including but not limited to bone defects, cartilage damage, and skin lesions whose extent varies from patient-to-patient.
In this study, two tissue analogs (articular cartilage and skin) were fabricated through the bioprinting of pre-cellularized bioinks. Ensuring adequate blending of a bioink with cell suspension that can ensure uniform cell distribution while preserving cell viability can be a challenge. Bioinks suitable for bioprinting via extrusion are often highly viscous and therefore require extensive mixing to ensure a homogenous blend. Mechanical damage to cells can occur under harsh mixing conditions and negatively affect viability. Studies have shown that most cell death during the inkjet printing process occurs during preparation such as mixing 7, 8 . While traditional mixing with agitation 9 may be sufficient for low viscosity bioinks suitable for inkjet printing 10 , mixing of cells into a high viscosity bioink more suitable for extrusion bioprinting is more difficult. Addressing this need, the use of mixing nozzles has become more popular for the blending of bioinks during the printing process 11 . These mixers have also been widely utilized in microfluidics research where the mixing of fluids with low Reynolds number is important 12 . The utilization of a continuous mixing process to blend a cell suspension into a bioink would allow for uniformity during the printing process. However, since cell suspensions possess low viscosity compared to a bioink, difficulties will arise in preventing sedimentation of the cells during the printing process 9, 13, 14 . Alternatively, the mixing of cells into a bioink prior to printing may address this issue.
To minimize cell death during blending into a bioink, we developed a technique based on a passive mixing unit to blend cells into a bioink in the minimal number of steps. The chaotic mixing generated through the flow of the materials through the mixing unit is sufficient to reproducibly . NOTE: In this protocol, human fibroblasts were utilized. 7 . Determine what cell density is desired in the final printed construct. Calculate using the following equations the concentration of the harvested cells that must be diluted to achieve this target final cell density. NOTE: In this protocol, a final cell density of 5 x 10 6 cells/mL was utilized. 
Mixing of Cell Suspension and Bioink
3. Blend the cells into the bioink using the passive mixing unit technique 1, 2, or 3 times prior to dispensing into a mold for cross-linking using 100 mM CaCl 2 . NOTE: To perform additional blends, mix the cell/bioink directly into a syringe rather than a cartridge. Then remix the blend through the mixing unit following the previous protocol but without the cell syringe component. 4. Blend the cells into a separate bioink using manual mechanical mixing via a spatula for durations of 30, 60, or 90 s. Transfer the mixtures (for each mixing time) into a mold for cross-linking using 100 mM CaCl 2 . 5. Transfer the samples to a well plate after the completion of cross-linking and culture under standard conditions. 6. After 1 day of culture, wash the constructs (n = 3 -4 per group) in serum-free cell culture medium for 30 min. Stain the cells in the constructs with a staining solution (4 µM Calcein AM, 1 µM Ethidium homodimer-1) for 30 min. 1. Wash two additional times, and incubate the samples in serum-free cell culture medium for a total of 1 h at 37 °C. Transfer the samples to a live cell imaging solution.
7. Acquire images via a digital color camera at 10X magnification using an inverted microscope with FITC and Texas Red filters, and analyze using image analysis software. 8. Randomly select three images from each construct for quantification of cell viability. 9. Calculate viability based on the ratio of live cells to total number of cells. Analyze the data via a one-way ANOVA followed by Tukey's multiple comparisons test.
Bioprinting of Cartilage Analogs with a Single Cell Type
1. Draw a 3D model of the desired tissue analog. Convert to a Gcode file for bioprinting and load the Gcode file on the bioprinter 1 . NOTE: In this protocol, a square structure with dimensions 4.8 x 4.8 x 0.9 mm 3 was exported as an STL file. A Gcode file was generated of the lattice structure using the following settings: layer thickness, 0.3 mm; infill pattern, rectilinear; infill density, 25%; speed, 10 mm/s. 2. Isolate and cryopreserve primary human nasal chondrocytes (hNC) from patients following the referenced protocol 1 .
3. Thaw and expand cryopreserved hNCs and expand once in monolayer culture using standard culture medium at 37 °C. Detach cells at 80 -90% confluence with a 0.5% trypsin/EDTA solution and count using a trypan blue exclusion protocol. All experiments were conducted using hNCs at passage 2. 4. Resuspend the hNCs at 100 x 10 6 cells/mL within 300 µL of culture medium supplemented with 10% fetal bovine serum, 1% penicillinstreptomycin, and 50 µg/mL ascorbic acid, in preparation for blending with the bioink. 5. Blend the hNC cell suspension into a nanocellulose/alginate based bioink following the passive mixing unit protocol at a 10:1 bioink:cell suspension ratio to obtain a final cell concentration of 9 x 10 6 cells/mL.
6. Ensure that the bioprinter is sterilized via UV exposure and wipe down with 70% ethanol. Maintain sterility by placing in a laminar flow cabinet. 7. Attach sterile printing nozzles to the cartridges containing the bioink/cell suspension blends and insert into the bioprinter. 8. Calibrate the bioprinter either manually or by the protocols specific to the printer. 9. Bioprint the lattice-structured, cell-laden constructs using the following printing parameters: 25G conical nozzle at a pressure of 25 kPa.
Bioprint cell-free constructs (blended with cell medium containing no cells) as a control. 10. Cross-link the constructs by adding an ionic solution of 100 mM CaCl 2 for 5 min. Rinse the constructs and incubate in culture medium under standard culture conditions (37 °C, 5% CO 2 , and 95% relative humidity). Change the media every second or third day. 11. Collect samples for histological analysis at weeks 2 and 4. Stain the samples for GAG production using an Alcian blue stain 18 .
Bioprinting of Skin Analogs with Two Cell Types
1. Draw a 3D model of the desired tissue analog and convert to a Gcode file for bioprinting. Load the Gcode file on the bioprinter. NOTE: In this protocol, a square structure with dimensions 4.8 x 4.8 x 0.9 mm 3 was exported as an STL file. Then a Gcode file was generated of the lattice structure using the following settings: layer thickness, 0.3 mm; infill pattern, rectilinear; infill density, 25%; speed, 10 mm/s. 2. Prepare the cells for blending into the bioink for bioprinting. For the fabrication of skin analogs, two cell types were utilized. The two cell types were blended into the bioink and bioprinting. 1. Obtain primary HDF. Maintain these cells in DMEM growth media supplemented with 10% fetal bovine serum, 1% penicillinstreptomycin, and 50 µg/mL ascorbic acid. Detach cells at 80 -90% confluence with a 0.5% trypsin/EDTA solution and count. 2. Isolate and cryopreserve primary hNC from patients following the referenced protocol 1 . Thaw and expand cryopreserved hNCs in monolayer culture. Detach cells at 80 -90% confluence with a 0.5% trypsin/EDTA solution and count.
3. Resuspend both cell types at 100 x 10 6 cells/mL within growth media. Mix the cell suspensions together at a 1:1 ratio to achieve a final total concentration of 100 x 10 6 cells/mL in 300 µL of media.
4. Blend the 50:50 cell suspension of HDF and hNC into a nanocellulose/alginate based bioink following the passive mixing unit protocol at a 10:1 bioink:cell suspension ratio to obtain a final cell concentration of 9 x 10 6 cells/mL.
5. Ensure that the bioprinter is sterilized or is placed in a laminar flow cabinet to maintain sterility. 6. Attach sterile printing nozzles to the cartridges containing the bioink/cell suspension blends and insert into the bioprinter. 7. Calibrate the bioprinter either manually or the protocols specific to the printer. 8. Bioprint the lattice-structured, cell-laden constructs using the following printing parameters: 25G conical nozzle at a pressure of 25 kPa. Bioprint cell-free constructs (blended with cell medium containing no cells) as a control. 9. Cross-link the constructs by adding an ionic solution of 100 mM CaCl 2 for 5 min. Rinse the constructs and incubate in culture medium under standard culture conditions (37 °C, 5% CO 2 , and 95% relative humidity). Change the media every second or third day. 10. Collect samples for histological analysis at weeks 2 and 4. Stain the samples for collagen I production using a Masson's trichrome stain
Discussion
As demonstrated in this manuscript, pre-cellularized bioinks were bioprinted to fabricate either cartilage or skin analogs that were cultured for up to 4 weeks. Cell viability after blending using the passive mixing unit technique was higher than the traditional mixing methods. Additionally, the simplification of the blending process using the mixing unit minimizes the number of handling steps and allows for better consistency in the extent of mixing. Ultimately, this results in better reproducibility in both cell distribution within the bioink, and across constructs and experimental groups. Deposition of tissue specific ECM components such as GAGs and collagen I was observed for both the cartilage and skin analogs, respectively after 4 weeks of culture. This indicates the flexibility of both the mixing technique and the chosen construct geometry to fabricate different tissue targets. The fabrication of both cartilage and skin analogs exhibited the flexibility of both the use of a nanocellulose-alginate bioink and the bioprinting technique for distinct engineered tissue targets. We will discuss two components of the study below: (1) the passive mixing unit technique, and (2) the behavior of cells within cartilage and skin analogs.
The development and the optimization of a technique for the blending of a cell suspension into a bioink was paramount for the fabrication of these constructs. Unlike traditional low viscosity hydrogel materials, the high viscosity of the bioinks resulted in difficulty in pre-cellularization of a bioink prior to printing. As an alternative to the traditional method of cell incorporation into a bioink, a protocol for the one-step mixing of a cell suspension into a viscous bioink was developed and discussed. Additionally, the practical application of this mixing technique in the fabrication of tissue constructs was evaluated. This one-step mixing approach has several advantages over traditional mixing techniques included controlled mixing ratio, minimization of high and irregular shear stresses, and a closed system to eliminate sample close in mixing vessels. However, there are several critical steps in this technique to ensure its advantages over traditional methods for cell/bioink blending. It is critical to ensure that the cells in the cell syringe are suspended and well mixed prior to blending. Too large of a time gap between the lifting and transfer of the cells in the syringe and starting the mixing process can cause the cells to sediment, which will result in uneven mixing and distribution into a printed filament. If sedimentation is observed, simple inversion (2 -3 times) of the passive mixing unit assembly immediately prior to mixing is sufficient to resuspend the cells and ensure a uniform distribution prior to blending. It is also critical that air bubbles in the syringes are eliminated or minimized prior to ensure that the mixing ratio remains constant. If large air bubbles remain in the bioink cartridge prior to blending, it is recommended that the solution be run through the mixing unit an additional time to ensure thorough mixing. If air bubbles remain, gentle tapping of the printing cartridge/syringe can displace residual air bubbles. Additionally, if multiple material blending (several mixing units or materials) is necessary for more complex constructs, the concentrations of the bioinks/cell suspensions to be mixed must be adjusted to ensure that after diluting through blending, the proper final concentration is still achieved.
In comparison to other blending techniques, the passive mixing unit is a novel approach to cellularize bioinks. Unlike other mixing techniques such as dual syringe mixing, or stirring with a spatula or other tool, the passive mixing unit allows more consistency in blending across batches and users. The nature of manual mixing techniques, such as a spatula mixing, results in greater user-to-user variation in the extent of and rate of mixing. Additionally, closed systems such as the passive mixing unit and dual syringe mixing have little to no sample loss compared to manual mixing within a Petri dish or tube.
Both tissue analogs fabricated in this manuscript consisted of a single type of bioink and either one or two cell types. However, the bioprinting of tissue analogs that consist of architectures that contain regions of distinct bioinks with distinct cell types may be necessary for the fabrication of more physiological tissue constructs 20, 21, 22 . More specialized bioinks with unique compositions or functionalities may be generated through the blending of several types of existing bioinks together to create multimaterial bioinks that have distinct compositions or functionalities 23, 24 . This may be particularly important at tissue transition regions such as the skin to subcutaneous layer or the cartilage to bone region of a tissue where a gradient of bioink composition 25, 26 may be necessary to ensure development of these critical regions found in native tissues 27 . Additionally, a mixing unit could be utilized to blend in growth factors and morphogens into the bioinks prior to bioprinting. The elimination of sample loss with the closed mixing system is attractive for the use of expensive and low concentration bioactive factors, where sample loss can result in a change to their final concentration within the bioprinted construct, particularly when gradients are involved.
A limitation with any mixing technique, including the passive mixing unit utilized in this study, is the risk of damage to mechanically sensitive cell types. For example, isolated stem cells such those from the bone marrow or embryo, or induced pluripotent stem cells are more susceptible to mechanical damage 28, 29 . The act of mixing imparts abnormal mechanical stresses on the cells due to the shear forces involved in the mixing process, and they must be balanced to preserve viability 30 . While the use of primary fibroblasts and chondrocytes in this study resulted in good viability (Figure 2) , more studies are necessary to determine safe mixing rates and ratios for more sensitive cell types. Until then, it is recommended that the mixing be performed under a steady slow rate to maximize viability. Additionally, the cell density chosen in this study was determined based on previous studies
